Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Preferred stock
Accumulated deficit
Beginning Balance at Jun. 30, 2020 $ 263 $ 11 $ 65,148 $ 21 $ 4,804 $ (69,721)
Beginning Balance, shares at Jun. 30, 2020   11,458,000        
Adgero merger (note 3) 16,725 $ 12 16,713      
Adgero merger, shares   12,011,000        
Issuance of Series C Preferred stock 25,028       25,028  
Series C placement agent warrants     3,287   (3,287)  
Series C Preferred stock share issuance costs (3,386)       (3,386)  
Deemed dividend recognized on beneficial conversion features of Series C Preferred stock issuance     3,181     (3,181)
Exercise of warrants 994 $ 1 993      
Exercise of warrants, shares   993,000        
Warrants issued for services 45   45      
Stock option expense 405   405      
Series A Preferred cash dividend (2)         (2)
Series B preferred stock dividend     5     (5)
Series B preferred stock dividend, shares   4,000        
Loss for the period (19,518)         (19,518)
Ending Balance at Sep. 30, 2020 20,554 $ 24 89,777 21 23,159 (92,427)
Ending Balance, shares at Sep. 30, 2020   24,466,000        
Beginning Balance at Jun. 30, 2020 263 $ 11 65,148 21 4,804 (69,721)
Beginning Balance, shares at Jun. 30, 2020   11,458,000        
Loss for the period (31,566)          
Ending Balance at Mar. 31, 2021 16,118 $ 32 100,828 21 19,726 (104,489)
Ending Balance, shares at Mar. 31, 2021   31,764,000        
Beginning Balance at Sep. 30, 2020 20,554 $ 24 89,777 21 23,159 (92,427)
Beginning Balance, shares at Sep. 30, 2020   24,466,000        
Series C Preferred stock share issuance costs (69)       (69)  
Conversion of Series B Preferred stock to common stock     268   (268)  
Conversion of Series B preferred stock to common stock, shares   10,000        
Conversion of Series C Preferred stock to common stock   $ 1 987   (988)  
Conversion of Series C preferred stock to common stock, shares   1,168,000        
Exercise of warrants 186   186      
Exercise of warrants, shares   186,000        
Warrants issued for services 183   183      
Stock options exercised 21   21      
Stock options exercised, Shares   35,000        
Stock option expense 2,125   2,125      
Series A Preferred cash dividend (2)         (2)
Series B preferred stock dividend     4     (4)
Series B preferred stock dividend, shares   3,000        
Loss for the period (5,413)         (5,413)
Ending Balance at Dec. 31, 2020 17,585 $ 25 93,551 21 21,834 (97,846)
Ending Balance, shares at Dec. 31, 2020   25,868,000        
Conversion of Series B Preferred stock to common stock     61   (61)  
Conversion of Series B preferred stock to common stock, shares   2,000        
Conversion of Series C Preferred stock to common stock   $ 3 2,115   (2,118)  
Conversion of Series C preferred stock to common stock, shares   2,379,000        
Series C Agent Warrants Exercised     (71)   71  
Exercise of warrants 3,219 $ 3 3,216      
Exercise of warrants, shares   3,478,000        
Warrants issued for services 210   210      
Stock options exercised 22 $ 1 21      
Stock options exercised, Shares   34,000        
Stock option expense 1,719   1,719      
Series A Preferred cash dividend (2)         (2)
Series B preferred stock dividend     6     (6)
Series B preferred stock dividend, shares   3,000        
Loss for the period (6,635)         (6,635)
Ending Balance at Mar. 31, 2021 16,118 $ 32 100,828 21 19,726 (104,489)
Ending Balance, shares at Mar. 31, 2021   31,764,000        
Beginning Balance at Jun. 30, 2021 10,581 $ 33 106,821 21 14,931 (111,225)
Beginning Balance, shares at Jun. 30, 2021   32,740,000        
Issuance of shares and warrants - net of issue costs 13,634 $ 7 13,627      
Issuance of shares and warrants - net of issue costs, shares   7,200,000        
Conversion of Series C Preferred stock to common stock   $ 1 1,255   (1,256)  
Conversion of Series C preferred stock to common stock, shares   1,467,000        
Exercise of 2020 Investor Warrants for cash 69   69      
Exercise of 2020 Investor Warrants for Cash, shares   69,000        
Exercise of pre-funded warrants for cash 5 $ 5        
Exercise of pre-funded warrants for cash, shares   4,800,000        
Warrants issued for services 31   31      
Stock option expense 811   811      
Series A Preferred cash dividend (2)         (2)
Series C Preferred stock dividend   $ 2 2,460     (2,462)
Series C Preferred stock dividend, shares   1,698,000        
Loss for the period (5,966)         (5,966)
Ending Balance at Sep. 30, 2021 19,163 $ 48 125,074 21 13,675 (119,655)
Ending Balance, shares at Sep. 30, 2021   47,974,000        
Beginning Balance at Jun. 30, 2021 10,581 $ 33 106,821 21 14,931 (111,225)
Beginning Balance, shares at Jun. 30, 2021   32,740,000        
Loss for the period (17,215)          
Ending Balance at Mar. 31, 2022 9,386 $ 49 127,670 21 12,554 (130,908)
Ending Balance, shares at Mar. 31, 2022   49,306,000        
Beginning Balance at Sep. 30, 2021 19,163 $ 48 125,074 21 13,675 (119,655)
Beginning Balance, shares at Sep. 30, 2021   47,974,000        
Conversion of Series C Preferred stock to common stock   $ 1 873   (874)  
Conversion of Series C preferred stock to common stock, shares   1,039,000        
Warrants issued for services 4   4      
Stock option expense 830   830      
Series A Preferred cash dividend (2)         (2)
Loss for the period (5,893)         (5,893)
Ending Balance at Dec. 31, 2021 14,102 $ 49 126,781 21 12,801 (125,550)
Ending Balance, shares at Dec. 31, 2021   49,013,000        
Conversion of Series C Preferred stock to common stock     247   (247)  
Conversion of Series C preferred stock to common stock, shares   293,000        
Stock option expense 642   642      
Series A Preferred cash dividend (2)         (2)
Loss for the period (5,356)         (5,356)
Ending Balance at Mar. 31, 2022 $ 9,386 $ 49 $ 127,670 $ 21 $ 12,554 $ (130,908)
Ending Balance, shares at Mar. 31, 2022   49,306,000